Dr. Mireia Crispin

Biography

Mireia Crispin is an Assistant Professor in the Department of Oncology at the University of Cambridge, where she leads a research group focused on developing multi-omic data integration models to understand how tumors evolve and respond to treatment. She co-leads the Ovarian Programme at the CRUK Cambridge Centre and the Mark Foundation Institute for Integrated Cancer Medicine. As the Chief Digital Officer at 52 North Health, an award-winning biotech startup, she aims to develop affordable at-home tests for cancer patients. Previously, Dr. Crispin worked at Memorial Sloan Kettering Cancer Center in New York and served as the Director of the Healthcare Innovation Programme at the Center for Governance of Change at IE University in Madrid, Spain, where she focused on the policy challenges of integrating AI and digital health in European healthcare systems. She holds a PhD in Particle Physics from the University of Oxford, which she completed in 2015. An accomplished researcher, she has authored 400 publications and has won numerous national and international awards, including being a finalist for the Cancer Research Horizons Early-Career Entrepreneur of the Year in 2022. Her research includes predictive modeling through machine learning applied to imaging data to anticipate cancer patients' responses to treatment, new technologies for spatially integrating multi-scale cancer data to reveal heterogeneity patterns, and contributions to the policy discussion surrounding the implications of AI in digital health.

Research Interests